Collagen Matrix Receives FDA 510(k) Clearance for Flexible Collagen Nerve Conduit

Collagen Matrix announced that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Flexible Collagen Nerve Conduit.

Advertisement

The conduit — a resorbable, flexible type I collagen tubular matrix — is intended for management of peripheral nerve injuries at nerve ends in the foot to reduce the formation of painful neuroma. It aims at helping people suffering from pain as a result of conditions such as Morton’s neuroma affecting the ball of the foot.

 

Collagen Matrix is a provider of collagen- and mineral-based extracellular matrices for tissue and organ repair and regeneration.  

More Articles on Devices:

Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.